ALYSSA SHAFFER: Open Payments
NPI 1750825170 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$408 in 7 payments from 4 companies in 2025. Trend: 2023 $1,376 · 2024 $0 · 2025 $408
Food & beverage: $408
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $216 |
| ABBVIE INC. | 2 | $99 |
| REVANCE THERAPEUTICS, INC. | 2 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
Products named: TREMFYA, SKYRIZI, DAXXIFY, ENTYVIO.
Industry payments across NY — which companies pay providers there.
